Learn about Mundipharma Australia and our global network.
See which prescription and non prescription products are in our portfolio.
Find out about what it is like to work with us and which roles we are recruiting for.
Read about our recent activities in the industry and in the community.
Delivering accredited education programs to healthcare professionals. […]
Ensuring secure, efficient and effective access to our range of products. […]
Actively looking for products offering a promising opportunity to patients. […]
Working with our overseas network to provide innovative healthcare products. […]
Established as a leader in the development and provision of medicines for pain, Mundipharma is a member of a global network of independent associated companies which are engaged in research, development, production and marketing of prescription medicines and consumer healthcare products.
Pharmaceutical sector leaders and experts joined government and NGO representatives to share their collective wisdom with young researchers, entrepreneurs and industry professionals at The Bridge Program’s Residential Training Program last week. The Bridge Program was launched in 2017 to boost the commercial output of Australian......
07 November, 2018Gloup™ makes swallowing tablets and capsules easier and is designed to have minimal impact on medication absorption. Mundipharma is proud to announce it has acquired the exclusive Australian and New Zealand distribution rights to the medication lubricant Gloup™, from Evomed Pty Limited (Evomed). Gloup™ is......
06 November, 2018Mundipharma today welcomed the announcement by Federal Health Minister Greg Hunt MP that Nyxoid® (naloxone 1.8mg) nasal spray has been registered in Australia as an antidote to opioid overdose.1-4 At the moment, naloxone is only available in Australia for intramuscular or intravenous administration. Nyxoid® has......
02 October, 2018Mundipharma has marked Prostate Cancer Awareness month by inviting leading urological surgeon, Associate Professor Paul Sved to share his insights from 20 years of clinical practice in the field. Employees outside the oncology business were eager to learn more about Mundipharma’s newest therapeutic area, after......
12 September, 2018
The 2018 Mundipharma ANZUP Uro-Oncology Clinical Research Fellowship has been awarded to Dr Kate Mahon, Medical Oncologist at Chris O’Brien Lifehouse, providing $60,000 to support her research into prostate cancer. This is the fifth annual Clinical Research Fellowship to be awarded in partnership with the......
17 July, 2018
Mundipharma Pty Limited (Mundipharma) has added two innovative physical therapy devices to its pain management portfolio, acquiring the exclusive Australian and New Zealand rights to the PAINmate® and ActiPatch® brands from Evomed Pty Limited (Evomed). “Mundipharma is committed to the multimodal approach to pain management,......
03 July, 2018
Sometimes the simplest things are the hardest to find. So we created a new line for everyday life, All Year Round he simplest things are the hardest to find. So we created a new line for everyday life, All Year Round.
Sometimes the simplest things are the hardest to find. So we created a new line for everyday life, All Year Round he simplest things are the hardest to find. So we created a new line for everyday life, All Year Round.
Sometimes the simplest things are the hardest to find. So we created a new line for everyday life, All Year Round he simplest things are the hardest to find. So we created a new line for everyday life, All Year Round.
Mundipharma proudly provides a broad range of effective products covering a variety of therapeutic areas, helping people better manage their health and improve their quality of life.
Mundipharma proudly provides a broad range of effective products covering a variety of therapeutic areas, helping people better manage their health and improve their quality of life.
